[HTML][HTML] Colorectal liver metastases: Current management and future perspectives

J Martin, A Petrillo, EC Smyth, N Shaida… - World Journal of …, 2020 - ncbi.nlm.nih.gov
The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

[HTML][HTML] Colorectal liver metastases: Current management and future perspectives

J Martin, A Petrillo, EC Smyth, N Shaida… - World Journal of …, 2020 - wjgnet.com
The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

[PDF][PDF] WJCO

J Martin, A Petrillo, EC Smyth, N Shaida, S Khwaja… - World, 2020 - core.ac.uk
The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

Colorectal liver metastases: Current management and future perspectives

J Martin, A Petrillo, EC Smyth… - World journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

[引用][C] Colorectal liver metastases: Current management and future perspectives

J Martin, A Petrillo, EC Smyth, N Shaida… - World Journal of …, 2020 - cir.nii.ac.jp
Colorectal liver metastases: Current management and future perspectives | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Colorectal liver metastases: Current management and future perspectives.

J Martin, A Petrillo, EC Smyth, N Shaida… - World Journal of …, 2020 - europepmc.org
The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

[PDF][PDF] WJCO

J Martin, A Petrillo, EC Smyth, N Shaida… - …, 2020 - pdfs.semanticscholar.org
The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

Colorectal liver metastases: Current management and future perspectives.

J Martin, A Petrillo, EC Smyth, N Shaida, S Khwaja… - 2020 - repository.cam.ac.uk
The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

Colorectal liver metastases: Current management and future perspectives

J Martin, A Petrillo, EC Smyth, N Shaida… - World Journal of …, 2020 - wjgnet.com
Figure 1 Biomarkers, molecular pathways, existing and emerging therapeutic targets in
colorectal cancer. A: Biomarkers and molecular pathways in colorectal cancer. Epidermal …

Colorectal liver metastases: Current management and future perspectives.

J Martin, A Petrillo, EC Smyth, N Shaida… - World Journal of …, 2020 - europepmc.org
The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …